Adipogenesis and lipid metabolism pathway genes

Adipogenesis and lipid metabolism pathway genes refer to a complex network of genetic factors that control the development of adipocytes and the biochemical processing of fats. This pathway includes master transcription factors such as Peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer-binding proteins (C/EBPs), which regulate the expression of genes involved in lipid uptake and storage (Source: PubMed, PMID: 22431289). These genes play a fundamental role in maintaining energy homeostasis and are often dysregulated in conditions like obesity, type 2 diabetes, and nonalcoholic fatty liver disease (Source: NIH). Pharmacological agents often target specific components of this pathway; for example, thiazolidinediones activate PPARγ to improve insulin sensitivity, while fibrates target PPARα to lower triglyceride levels (Source: PubChem). Because this term describes a broad biological process involving many different proteins rather than a single molecular entity, it is not classified as a discrete therapeutic target. Instead, it serves as a framework for understanding the multi-step regulation of metabolic health and disease (Source: StatPearls).

Other names

Adipogenic gene programLipid metabolic networkAdipocyte differentiation pathwayLipid metabolism gene set

Drugs interacting with this pathway typically function by activating specific nuclear receptors like PPAR-gamma to enhance adipocyte differentiation and insulin sensitivity, or by inhibiting enzymes like HMG-CoA reductase and fatty acid synthase to modulate lipid levels.